Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)

Clinical trial NCT02410590 · WITHDRAWN

Trial details

NCT number: NCT02410590
Sponsor: Merck Sharp & Dohme LLC
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blockade

Start date: 2015-07-01
Primary completion: 2016-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.